Kim Moinay, Cho Young Hyun, Kim Jeong Hoon, Kim Chang Jin, Kwon Do Hoon
Graduate School of Medicine, University of Ulsan, Seoul, 05505, Republic of Korea.
Department of Neurological Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, 05505, Republic of Korea.
Clin Neurol Neurosurg. 2017 Mar;154:51-58. doi: 10.1016/j.clineuro.2017.01.013. Epub 2017 Jan 20.
OBJECTIVES: Surgical resection is a primary indication for intracranial meningioma. Radiosurgery is also an excellent treatment modality for postoperative residual tumors, or tumors in high-risk locations, such as the skull base. Despite multimodality treatments, there are some cases in which radiosurgery fails and surgical resection or re-radiosurgery is required. However, there has not been a comprehensive study focusing on the causes of secondary treatment for local recurrence or a new mass that develops outside the target area after radiosurgery. Hence, we analyzed the causes of radiosurgical failure in patients with meningioma. METHODS: From 2000 to 2015, we retrospectively reviewed 1086 patients who underwent gamma knife radiosurgery (GKRS) for intracranial meningioma at the Asan Medical Center. Multiple meningiomas or tumors with a volume greater than 7000mm were excluded. All patients had a minimum follow-up of 12 months. Finally, 771 patients were enrolled in this study. Clinical symptoms and brain MRI findings were assessed by neurosurgeons. When the tumor size increased and was accompanied by newly developed neurological symptoms, further management was considered (e.g. microsurgical resection and stereotactic radiosurgery). Histological analyses of the resected tumors were performed by neuropathologists. RESULTS: Among the 771 patients, tumor growth was observed in 60 patients (7.78%). Seven patients showed transient tumor growth after GKRS. These patients have been under close observation without any further treatment. Thirty patients (3.89%) underwent re-radiosurgery for tumor control. Another 23 patients underwent procedures other than re-radiosurgery; 8 underwent microsurgical resection, 3 underwent cyber knife radiosurgery (CKRS), 1 underwent radiation therapy, and 8 were closely followed-up. Three patients visited other clinics or were lost to follow-up. Of the remaining 30 patients, 22 (group 1) underwent microsurgical resection prior to their initial course of GKRS and the other 8 (group 2) were treated only with re-radiosurgery. In group 1, recurrence rates after radiosurgery were 2.47% (n=19) and 0.39% (n=3) for local and distant recurrence, respectively. In group 2, recurrence rates after radiosurgery were 0.52% (n=4) and 0.52% (n=4) for local and distant recurrence, respectively. An analysis was performed to determine the factors that may result in differences between the two groups. Of the many variables, local recurrence (p=0.0331, Fisher's exact test) was the only significant factor. CONCLUSION: We analyzed the causes of radiosurgical failure in meningioma patients and observed that microsurgery before radiosurgery was significantly associated with a high local recurrence rate compared with primary radiosurgery. Furthermore, the percentage of local recurrence cases that required secondary radiosurgery was as low as 2.98%. This result is comparable with that of microsurgical resection, which is the mainstay of treatment for meningioma.
目的:手术切除是颅内脑膜瘤的主要治疗指征。放射外科也是术后残留肿瘤或位于高风险部位(如颅底)肿瘤的一种极佳治疗方式。尽管采用了多模式治疗,但仍有一些病例放射外科治疗失败,需要进行手术切除或再次放射外科治疗。然而,尚未有一项全面的研究聚焦于放射外科治疗后局部复发或靶区外新出现肿块的二次治疗原因。因此,我们分析了脑膜瘤患者放射外科治疗失败的原因。 方法:2000年至2015年,我们回顾性分析了在峨山医学中心接受颅内脑膜瘤伽玛刀放射外科治疗(GKRS)的1086例患者。排除多发脑膜瘤或体积大于7000mm³的肿瘤。所有患者至少随访12个月。最终,771例患者纳入本研究。神经外科医生评估临床症状和脑部MRI检查结果。当肿瘤大小增加并伴有新出现的神经症状时,考虑进一步治疗(如显微手术切除和立体定向放射外科治疗)。切除肿瘤的组织学分析由神经病理学家进行。 结果:771例患者中,60例(7.78%)观察到肿瘤生长。7例患者在GKRS后出现短暂肿瘤生长。这些患者一直在密切观察中,未进行任何进一步治疗。30例患者(3.89%)接受了再次放射外科治疗以控制肿瘤。另外23例患者接受了除再次放射外科治疗之外的其他治疗;8例接受了显微手术切除,3例接受了射波刀放射外科治疗(CKRS),1例接受了放射治疗,8例进行了密切随访。3例患者去了其他诊所或失访。在其余30例患者中,22例(第1组)在初次GKRS治疗前接受了显微手术切除,另外8例(第2组)仅接受了再次放射外科治疗。在第1组中,放射外科治疗后的局部复发率和远处复发率分别为2.47%(n = 19)和0.39%(n = 3)。在第2组中,放射外科治疗后的局部复发率和远处复发率分别为0.52%(n = 4)和0.52%(n = 4)。进行分析以确定可能导致两组之间差异的因素。在众多变量中,局部复发(P = 0.0331,Fisher精确检验)是唯一的显著因素。 结论:我们分析了脑膜瘤患者放射外科治疗失败的原因,观察到与初次放射外科治疗相比,放射外科治疗前进行显微手术与较高的局部复发率显著相关。此外,需要二次放射外科治疗的局部复发病例百分比低至2.98%。这一结果与脑膜瘤主要治疗方式显微手术切除的结果相当。
Clin Neurol Neurosurg. 2017-3
Clin Neurol Neurosurg. 2017-2
Clin Neurol Neurosurg. 2016-3
J Neurosurg. 2017-2-3
J Neurosurg. 2015-2
Acta Neurochir (Wien). 2000
World Neurosurg. 2017-5
Acta Neurochir (Wien). 2020-9
World Neurosurg X. 2019-3-7